tiprankstipranks
Viva Biotech Holdings (HK:1873)
:1873
Hong Kong Market
1873
Viva Biotech Holdings
RESEARCH TOOLSreports
Want to see HK:1873 full AI Analyst Report?

Viva Biotech Holdings (1873) Financial Statements

4 Followers

Viva Biotech Holdings Financial Overview

Viva Biotech Holdings's market cap is currently HK$3.07B. The company's EPS TTM is HK$0.1011; its P/E ratio is 17.96; Viva Biotech Holdings is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 1.73B¥ 1.99B¥ 2.16B¥ 2.38B¥ 2.10B
Gross Profit¥ 655.56M¥ 687.40M¥ 738.43M¥ 815.68M¥ 650.98M
Operating Income¥ 193.25M¥ 229.67M¥ 192.68M¥ 269.35M¥ 236.90M
EBITDA¥ 385.38M¥ 428.00M¥ 391.01M¥ 436.35M¥ 369.94M
Net Income¥ 219.76M¥ 167.29M¥ -116.11M¥ -528.48M¥ 287.55M
Balance Sheet
Cash & Short-Term Investments¥ 1.13B¥ 941.58M¥ 1.04B¥ 678.57M¥ 800.95M
Total Assets¥ 7.20B¥ 7.05B¥ 7.45B¥ 7.92B¥ 8.04B
Total Debt¥ 1.33B¥ 1.28B¥ 1.90B¥ 2.82B¥ 2.65B
Net Debt¥ 221.91M¥ 342.47M¥ 866.89M¥ 2.14B¥ 1.85B
Total Liabilities¥ 3.19B¥ 3.23B¥ 3.76B¥ 4.32B¥ 4.13B
Stockholders' Equity¥ 4.00B¥ 3.80B¥ 3.69B¥ 3.60B¥ 3.91B
Cash Flow
Free Cash Flow¥ 88.02M¥ 182.32M¥ 195.57M¥ 136.72M¥ -487.35M
Operating Cash Flow¥ 206.04M¥ 373.99M¥ 383.40M¥ 386.05M¥ 77.83M
Investing Cash Flow¥ -93.76M¥ 185.90M¥ 439.17M¥ -372.80M¥ -868.84M
Financing Cash Flow¥ 36.61M¥ -657.76M¥ -429.50M¥ -143.20M¥ -653.16M
Currency in CNY

Viva Biotech Holdings Earnings and Revenue History

Income Statement >

Viva Biotech Holdings Debt to Assets

Balance Sheet >

Viva Biotech Holdings Cash Flow

Cash Flow >

Viva Biotech Holdings Forecast EPS vs Actual EPS

Earnings >